Abstract. Emerging microarray technologies allow genotyping of long genome sequences resulting in huge amount of data. A key challenge is to provide an accurate phasing of very long single nucleotide polymorphism (SNP) sequences. In this paper we explore phasing of genotypes with 2 SNPs adjusted to the non-random mating model and then apply it to the haplotype inference of complete genotypes using maximum spanning trees. The runtime of the algorithm is O(nm(n + m)), where n and m are the number of genotypes and SNPs, respectively. The proposed phasing algorithm (2SNP) can be used for comparatively accurate phasing of large number of very long genome sequences. On datasets across 79 regions from HapMap[7] 2SNP is several orders of magnitude ...
The next phase of human genomics will involve large-scale screens of populations for significant DNA...
A major use of the 1000 Genomes Project (1000GP) data is genotype imputation in genome-wide associat...
A phase transition is taking place today. The amount of data generated by genome re-sequencing techn...
A Single Nucleotide Polymorphism (SNP) is a position in the genome at which two or more of the possi...
Haplotype phasing represents an essential step in studying the association of genomic polymorphisms ...
The determination of feature maps, such as STSs (sequence tag sites), SNPs (single nucleotide polymo...
Abstract Background Knowing the phase of marker genotype data can be useful in genome-wide associati...
Critical to the understanding of the genetic basis for complex diseases is the modeling of human var...
When we sequence a diploid individual, the output actually comprises two genomes: one from the pater...
Genotype microarrays assay hundreds of thousands of genetic variants on an individual's genome. The ...
Phasing genotypes from sequence data is an important step betweendata gathering and downstream analy...
Critical to the understanding of the genetic basis for com-plex diseases is the modeling of human va...
The next phase of human genomics will involve large-scale screens of populations for signif-icant DN...
AbstractRecent technologies for typing single nucleotide polymorphisms (SNPs) across a population ar...
A haplotype is the sequence of nucleotides along a single chromosome. As humans, we have 23 pairs of...
The next phase of human genomics will involve large-scale screens of populations for significant DNA...
A major use of the 1000 Genomes Project (1000GP) data is genotype imputation in genome-wide associat...
A phase transition is taking place today. The amount of data generated by genome re-sequencing techn...
A Single Nucleotide Polymorphism (SNP) is a position in the genome at which two or more of the possi...
Haplotype phasing represents an essential step in studying the association of genomic polymorphisms ...
The determination of feature maps, such as STSs (sequence tag sites), SNPs (single nucleotide polymo...
Abstract Background Knowing the phase of marker genotype data can be useful in genome-wide associati...
Critical to the understanding of the genetic basis for complex diseases is the modeling of human var...
When we sequence a diploid individual, the output actually comprises two genomes: one from the pater...
Genotype microarrays assay hundreds of thousands of genetic variants on an individual's genome. The ...
Phasing genotypes from sequence data is an important step betweendata gathering and downstream analy...
Critical to the understanding of the genetic basis for com-plex diseases is the modeling of human va...
The next phase of human genomics will involve large-scale screens of populations for signif-icant DN...
AbstractRecent technologies for typing single nucleotide polymorphisms (SNPs) across a population ar...
A haplotype is the sequence of nucleotides along a single chromosome. As humans, we have 23 pairs of...
The next phase of human genomics will involve large-scale screens of populations for significant DNA...
A major use of the 1000 Genomes Project (1000GP) data is genotype imputation in genome-wide associat...
A phase transition is taking place today. The amount of data generated by genome re-sequencing techn...